Pillar Pacific Capital Management’s Kura Oncology KURA Stock Holding History

Pillar Pacific Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$467K	Sell	16,500 -15,000	-48%	-$475K	0.04%	219
2020 Q4	$1.03M	Hold	31,500	–	–	0.09%	142
2020 Q3	$965K	Hold	31,500	–	–	0.09%	137
2020 Q2	$513K	Hold	31,500	–	–	0.05%	179
2020 Q1	$313K	Buy	31,500 +5,500	+21%	+$63K	0.04%	204
2019 Q4	$357K	Hold	26,000	–	–	0.04%	216
2019 Q3	$395K	Sell	26,000 -1,000	-4%	-$17.8K	0.04%	192
2019 Q2	$531K	Sell	27,000 -1,100	-4%	-$18.3K	0.06%	173
2019 Q1	$466K	Sell	28,100 -1,000	-3%	-$15.4K	0.05%	176
2018 Q4	$409K	Hold	29,100	–	–	0.05%	181
2018 Q3	$510K	Hold	29,100	–	–	0.06%	182
2018 Q2	$530K	Buy	29,100 +1,000	+4%	+$16.9K	0.06%	175
2018 Q1	$527K	Sell	28,100 -1,750	-6%	-$34.1K	0.06%	172
2017 Q4	$457K	Sell	29,850 -650	-2%	-$9.58K	0.06%	186
2017 Q3	$456K	Hold	30,500	–	–	0.06%	186
2017 Q2	$284K	Hold	30,500	–	–	0.04%	244
2017 Q1	$268K	Hold	30,500	–	–	0.04%	257
2016 Q4	$180K	Hold	30,500	–	–	0.03%	291
2016 Q3	$191K	Buy	+30,500	New	+$155K	0.03%	289

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pillar Pacific Capital Management's KURA Position: Q1 2021 in Review

Pillar Pacific Capital Management reduced its Kura Oncology (KURA) stake by 48% in Q1 2021, selling an estimated $475K and leaving 16,500 shares worth $467K. The position accounts for 0.04% of the portfolio, ranked #219.

Pillar Pacific Capital Management first reported a position in KURA in Q3 2016 and has held it in 19 quarters since. The position peaked at $1.03M in Q4 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q1 2021.

Pillar Pacific Capital Management held 16,500 shares of Kura Oncology worth $467K as of Q1 2021.
Pillar Pacific Capital Management sold 15,000 Kura Oncology shares in Q1 2021, an estimated $475K.
Kura Oncology made up 0.04% of Pillar Pacific Capital Management's portfolio in Q1 2021, its #219 holding.
Pillar Pacific Capital Management first reported a position in Kura Oncology in Q3 2016 and has held it in 19 quarters since.
Pillar Pacific Capital Management's Kura Oncology position peaked at $1.03M in Q4 2020.
171 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2021.

Based on Pillar Pacific Capital Management's 13F filing for Q1 2021, filed 4 May 2021.